KLF4 promotes angiogenesis by activating VEGF signaling in human retinal microvascular endothelial cells

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Wang, Yinan ^a,b   Yang, Chuanhe ^a   Gu, Qingqing ^a   Sims, Michelle ^a   Gu, Weiwang ^b   Pfeffer, Lawrence M ^a   Yue, Junming ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; VASCULOTROPIN; KRUPPEL LIKE FACTOR; SMALL INTERFERING RNA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA CELL; TRANSCRIPTION REGULATION; CELL CULTURE; CELL MOTION; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; METABOLISM; PHYSIOLOGY; RETINA; RETINA BLOOD VESSEL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NEOVASCULARIZATION, PHYSIOLOGIC; RETINA; RETINAL VESSELS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84938512977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130341     Document Type: Article

References (39)

1. Yang Y, Yang K, Li Y, Li X, Sun Q, Meng H, et al. Decursin inhibited proliferation and angiogenesis of endothelial cells to suppress diabetic retinopathy via VEGFR2. Mol Cell Endocrinol. 2013; 378(1-2):46-52. doi: 10.1016/j.mce.2012.06.021 PMID: 22750719
2. Yang W, Yu X, Zhang Q, Lu Q, Wang J, Cui W, et al. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Exp Eye Res. 2013; 115:96-105. doi: 10.1016/j.exer.2013.06.011 PMID: 23810809
3. Yang Z, Wang H, Jiang Y, Hartnett ME. VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis. Am J Pathol. 2014; 184(4):1230-9. doi: 10.1016/j.ajpath.2013.12.023 PMID: 24630601
4. Barot M, Gokulgandhi MR, Patel S, Mitra AK. Microvascular complications and diabetic retinopathy: recent advances and future implications. Future Med Chem. 2013; 5(3):301-14. doi: 10.4155/fmc.12.206 PMID: 23464520
5. Shibuya M. Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium. 2006; 13(2):63-9. PMID: 16728325
6. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol. 2006; 39(5):469-78. PMID: 17002866
7. List AF. Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. Oncologist. 2001; 6 Suppl 5:24-31. PMID: 11700389
8. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol. 2000; 157(1):135-44. PMID: 10880384
9. Shibuya M. VEGF-VEGFR Signals in Health and Disease. Biomol Ther (Seoul). 2014; 22(1):1-9. doi: 10.4062/biomolther.2013.113 PMID: 24596615
10. A view on new drugs for macular degeneration. Drug Ther Bull. 2007; 45(7):49-52. PMID: 17718304
11. Cleaver N, Ramirez J, Gildenberg S. Cutaneous lupus erythematosus in a patient undergoing intravitreal bevacizumab injections: case report and review of the literature. J Drugs Dermatol. 2013; 12(9):1052-5. PMID: 24002156
12. Jang JH, Kim KH, Lee SJ, Park JM. Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma. Korean J Ophthalmol. 2012; 26(6):478-80. doi: 10.3341/kjo.2012.26.6.478 PMID: 23204807
13. Gambrelle J, Missotten G, Delhoum S, Desjardins L. Intravitreal injection of anti-VEGF and diagnosis of primary intraocular central nervous system lymphoma. J Fr Ophtalmol. 2013; 36(5):431-4. doi: 10.1016/j.jfo.2012.11.005 PMID: 23306179
14. Das A, Fernandez-Zapico ME, Cao S, Yao J, Fiorucci S, Hebbel RP, et al. Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J Biol Chem. 2006; 281(51):39105-13. PMID: 17071613
15. Pei J, Grishin NV. A new family of predicted Kruppel-like factor genes and pseudogenes in placental mammals. PLoS One. 2013; 8(11):e81109. doi: 10.1371/journal.pone.0081109 PMID: 24244731
16. Boon RA, Urbich C, Fischer A, Fontijn RD, Seeger FH, Koyanagi M, et al. Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells. European heart journal. 2011; 32(3):371-7. doi: 10.1093/eurheartj/ehq137 PMID: 20494899
17. Nagai R, Suzuki T, Aizawa K, Shindo T, Manabe I. Significance of the transcription factor KLF5 in cardiovascular remodeling. Journal of thrombosis and haemostasis: JTH. 2005; 3(8):1569-76. PMID: 16102021
18. Yang DH, Hsu CF, Lin CY, Guo JY, Yu WC, Chang VH. Kruppel-like factor 10 upregulates the expression of cyclooxygenase 1 and further modulates angiogenesis in endothelial cell and platelet aggregation in gene-deficient mice. The international journal of biochemistry & cell biology. 2013; 45(2):419-28.
19. Helbing T, Volkmar F, Goebel U, Heinke J, Diehl P, Pahl HL, et al. Kruppel-like factor 15 regulates BMPER in endothelial cells. Cardiovasc Res. 2010; 85(3):551-9. doi: 10.1093/cvr/cvp314 PMID: 19767294
20. Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, et al. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor beta-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol. 2012; 32(5):941-53. doi: 10.1128/MCB.06306-11 PMID: 22203039
21. Lin ZS, Chu HC, Yen YC, Lewis BC, Chen YW. Kruppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. PLoS One. 2012; 7(8):e43593. doi: 10.1371/journal.pone.0043593 PMID: 22937066
22. Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, Chodosh LA, et al. Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia. 2011; 13(7):601-10. PMID: 21750654
23. Chen Z, Wang Y, Liu W, Zhao G, Lee S, Balogh A, et al. Doxycycline inducible Kruppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells. PLoS One. 2014; 9(8):e105331. doi: 10.1371/journal.pone.0105331 PMID: 25137052
24. Huang TS, Chen YJ, Chou TY, Chen CY, Li HY, Huang BS, et al. Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells. Journal of cellular and molecular medicine. 2014; 18(7):1358-71. doi: 10.1111/jcmm.12300 PMID: 24758741
25. Ptaszynska MM, Pendrak ML, Stracke ML, Roberts DD. Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration. Molecular cancer research: MCR. 2010; 8(3):309-21. doi: 10.1158/1541-7786.MCR-09-0288 PMID: 20197381
26. Yagi H, Yotsumoto F, Miyamoto S. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition. Molecular cancer therapeutics. 2008; 7(10):3441-51. doi: 10.1158/1535-7163.MCT-08-0417 PMID: 18852147
27. Fantozzi A, Gruber DC, Pisarsky L, Heck C, Kunita A, Yilmaz M, et al. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Cancer research. 2014; 74(5):1566-75. doi: 10.1158/0008-5472.CAN-13-1641 PMID: 24413534
28. Shiozaki A, Bai XH, Shen-Tu G, Moodley S, Takeshita H, Fung SY, et al. Claudin 1 mediates TNFalpha-induced gene expression and cell migration in human lung carcinoma cells. PloS one. 2012; 7(5):e38049. doi: 10.1371/journal.pone.0038049 PMID: 22675434
29. Zheng X, Li A, Zhao L, Zhou T, Shen Q, Cui Q, et al. Key role of microRNA-15a in the KLF4 suppressions of proliferation and angiogenesis in endothelial and vascular smooth muscle cells. Biochem Biophys Res Commun. 2013; 437(4):625-31. doi: 10.1016/j.bbrc.2013.07.017 PMID: 23867820
30. Hale AT, Tian H, Anih E, Recio FO III, Shatat MA, Johnson T, et al. Endothelial Kruppel-like factor 4 regulates angiogenesis and the Notch signaling pathway. J Biol Chem. 2014; 289(17):12016-28. doi: 10.1074/jbc.M113.530956 PMID: 24599951
31. Browning AC, Halligan EP, Stewart EA, Swan DC, Dove R, Samaranayake GJ, et al. Comparative gene expression profiling of human umbilical vein endothelial cells and ocular vascular endothelial cells. Br J Ophthalmol. 2012; 96(1):128-32. doi: 10.1136/bjophthalmol-2011-300572 PMID: 22028475
32. Yue J, Sheng Y, Ren A, Penmatsa S. A miR-21 hairpin structure-based gene knockdown vector. Biochem Biophys Res Commun. 2010; 394(3):667-72. doi: 10.1016/j.bbrc.2010.03.047 PMID: 20226761
33. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, et al. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem. 2001; 276(18):15240-8. PMID: 11278365
34. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol. 1997; 17(9):5629-39. PMID: 9271438
35. Chiplunkar AR, Curtis BC, Eades GL, Kane MS, Fox SJ, Haar JL, et al. The Kruppel-like factor 2 and Kruppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis. BMC developmental biology. 2013; 13:40. doi: 10.1186/1471-213X-13-40 PMID: 24261709
36. Villarreal G Jr, Zhang Y, Larman HB, Gracia-Sancho J, Koo A, Garcia-Cardena G. Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. Biochemical and biophysical research communications. 2010; 391(1):984-9. doi: 10.1016/j.bbrc.2009.12.002 PMID: 19968965
37. Bhattacharya R, Senbanerjee S, Lin Z, Mir S, Hamik A, Wang P, et al. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. The Journal of biological chemistry. 2005; 280(32):28848-51. PMID: 15980434
38. Wara AK, Foo S, Croce K, Sun X, Icli B, Tesmenitsky Y, et al. TGF-beta1 signaling and Kruppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization. Blood. 2011; 118(24):6450-60. doi: 10.1182/blood-2011-06-363713 PMID: 21828131
39. Bertolino P, Deckers M, Lebrin F, ten Dijke P. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest. 2005; 128(6 Suppl):585S-90S. PMID: 16373850